These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38267003)

  • 1. Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical Review.
    Dammann I; Rohleder C; Leweke FM
    Pharmacopsychiatry; 2024 May; 57(3):115-132. PubMed ID: 38267003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scoping review of the use of cannabidiol in psychiatric disorders.
    Kirkland AE; Fadus MC; Gruber SA; Gray KM; Wilens TE; Squeglia LM
    Psychiatry Res; 2022 Feb; 308():114347. PubMed ID: 34952255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic role of Cannabidiol in mental health: a systematic review.
    Khan R; Naveed S; Mian N; Fida A; Raafey MA; Aedma KK
    J Cannabis Res; 2020 Jan; 2(1):2. PubMed ID: 33526132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
    Bonaccorso S; Ricciardi A; Zangani C; Chiappini S; Schifano F
    Neurotoxicology; 2019 Sep; 74():282-298. PubMed ID: 31412258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for cannabidiol in psychiatry?
    Khoury JM; Neves MCLD; Roque MAV; Queiroz DAB; Corrêa de Freitas AA; de Fátima Â; Moreira FA; Garcia FD
    World J Biol Psychiatry; 2019 Feb; 20(2):101-116. PubMed ID: 28112021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of cannabidiol trials in neurodevelopmental disorders.
    Parrella NF; Hill AT; Enticott PG; Barhoun P; Bower IS; Ford TC
    Pharmacol Biochem Behav; 2023 Sep; 230():173607. PubMed ID: 37543051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
    Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
    Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.
    Elms L; Shannon S; Hughes S; Lewis N
    J Altern Complement Med; 2019 Apr; 25(4):392-397. PubMed ID: 30543451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
    Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
    Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder.
    Hua DY; Hindocha C; Baio G; Lees R; Shaban N; Morgan CJ; Mofeez A; Curran HV; Freeman TP
    Transl Psychiatry; 2023 Apr; 13(1):131. PubMed ID: 37085531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
    Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
    BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):230-240. PubMed ID: 35881851
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
    O'Sullivan SE; Stevenson CW; Laviolette SR
    Cannabis Cannabinoid Res; 2021; 6(1):7-18. PubMed ID: 33614948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review.
    Matheson J; Bourgault Z; Le Foll B
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
    Stanciu CN; Brunette MF; Teja N; Budney AJ
    Psychiatr Serv; 2021 Apr; 72(4):429-436. PubMed ID: 33530732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.